Lung Function in Patients With Early Type 2 Diabetes Mellitus
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03167918
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 200 participants
- Sponsor
- Liaoning University of Traditional Chinese Medicine
- Registry
-
NCT03167918
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03167918. Randomized; double masking; primary purpose treatment. Start 2014-07-21 (actual); primary completion 2017-04-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Lung Function in Patients With Early Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Condition
- Pulmonary Function
- Intervention (Drug)
- Calcium Dobesilate
- Intervention (Drug)
- Xuefuzhuyu Decoction
- Intervention (Drug)
- Xuefuzhuyu Decoction & Calcium dobesilate
- Intervention (Drug)
- metformin
- Intervention (Drug)
- Mecobalamin Tablets
- Lead sponsor
- Liaoning University of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct03167918- Content hash
e02e07204f99d7fbabbaf582d1bc30eb2721100f39ba8ccc92553281b46a07d2